Comment & Analysis

Yesterday’s US approval of idelalisib, Gilead Sciences’ first oncology drug, should have been a ...

Many companies would give a great deal to know what methods of persuasion Proteus Digital Health is ...

Jakafi's failure to prove that it can control polycythaemia vera (PV) symptoms better than ...

MedTech

EventAnalyzer

Latest
 

Market Moving Events

EP Vantage Interviews